Journals / İstanbul Medical Journal / 2019 / Cilt: 20 - Sayı: 1

Robotic Rectal Cancer Surgery with the da Vinci Xi System: First 100 Cases

da Vinci Xi Sistemi ile Robotik Rektum Kanseri Cerrahisi: İlk 100 Olgu

Pages
1–7
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Themean length of hospital stay was 6.6±3.6 days and the overallpostoperative morbidity rate was 25%.Conclusion: The da Vinci Xi model enables rectal canceroperations to be performed in a fully robotic fashion.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The da Vinci Xi system, the latest model ofthe robotic technology, is proposed to enable multiquadrantabdominal surgery to be performed in a fully robotic approachwithout the need for a laparoscopic assistance, robot re-dockingor re-positioning of the trocars.
📊
Key Findings & Data:In this study, we aimed to evaluatethe feasibility of the Xi robot use in rectal cancer surgery, amultiquadrant surgical procedure.Methods: Patients undergoing robotic mezorectal excision forrectal adenocarcinoma using the da Vinci Xi system betweenDecember 2014 and June 2017 were included in this study.Data were collected prospectively and analyzed retrospectively.Demographic data, perioperative clinical findings,histopathologic data and postoperative 30-day outcomes wereanalyzed.Results: One hundred patients were included in this study.There were 57 male and 43 female patients with a mean age of61.4±12.3 years.
💡
Conclusion & Impact:Themean length of hospital stay was 6.6±3.6 days and the overallpostoperative morbidity rate was 25%.Conclusion: The da Vinci Xi model enables rectal canceroperations to be performed in a fully robotic fashion.
🔬Design:Modeling & Simulation
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: The da Vinci Xi system, the latest model ofthe robotic technology, is proposed to enable multiquadrantabdominal surgery to be performed in a fully robotic approachwithout the need for a laparoscopic assistance, robot re-dockingor re-positioning of the trocars. However, the literature haslimited data on this topic. In this study, we aimed to evaluatethe feasibility of the Xi robot use in rectal cancer surgery, amultiquadrant surgical procedure.Methods: Patients undergoing robotic mezorectal excision forrectal adenocarcinoma using the da Vinci Xi system betweenDecember 2014 and June 2017 were included in this study.Data were collected prospectively and analyzed retrospectively.Demographic data, perioperative clinical findings,histopathologic data and postoperative 30-day outcomes wereanalyzed.Results: One hundred patients were included in this study.There were 57 male and 43 female patients with a mean age of61.4±12.3 years. Low anterior resection and abdominoperinealrecetion were performed in 90 and 10 patients, respectively.In all the operations, the abdominal and pelvic stages of theprocedure were completed robotically without a need fordual docking or trocar re-positioning. The mean operativetime was 328.4±105.8 min and blood loss was 131.7±170.3mL. Intraoperative complication occurred in 2 patients (2%).Two procedures were converted to open surgery (2%). Themean number of harvested lymph nodes was 25.3±12.0.All the surgical margins were clear except for four patients(4%). The rate of incomplete mesorectal fascia was 3.2%. Themean length of hospital stay was 6.6±3.6 days and the overallpostoperative morbidity rate was 25%.Conclusion: The da Vinci Xi model enables rectal canceroperations to be performed in a fully robotic fashion. Thisfeature of the robot helps surgeon to benefit optimally fromthe advantages robotic surgery in all stages of the procedure.

Özet

Amaç: Robot teknolojisinin en güncel modeli olan da Vinci Xi sisteminin multikadran karın ameliyatlarını laparoskopi yardımı olmadan, robotu tekrar konuşlandırma veya trokar pozisyonunda değişiklik gerektirmeden tamamen robot ile yapılmasını mümkün kıldığı öne sürülmektedir. Ancak bu konu üzerinde literatür verisi sınırlıdır. Bu çalışmada multikadran bir cerrahi olan rektum kanseri ameliyatında Xi robot kullanımının uygulanabilirliğini değerlendirmeyi amaçladık. Yöntemler: Çalışmaya Aralık 2014 ile Haziran 2017 tarihleri arasında rektum adenokanseri tanısı ile da Vinci Xi sistemi kullanılarak robotik mezorektal eksizyon ameliyatı yapılan hastalar alındı. Veriler prospektif kaydedildi ve retrospektif olarak incelendi. Hastaların demografik bilgileri, intraoperatif bulgular, histopatolojik veriler ve postoperatif 30 gün sonuçları değerlendirildi. Bulgular: Çalışmaya toplam 100 hasta dahil edildi. Hastaların 57’si erkek, 43’i kadın, ortalama yaş 61,4±12,3 yıl idi. Doksan hastaya aşağı anteriyor rezeksiyon ve 10 hastaya abdominoperineal rezeksiyon uygulandı. Tüm ameliyatlarda karın ve pelvis aşamaları robotun ikinci defa konuşlandırılmasına gerek duyulmadan ve trokarların yeri değiştirilmeden tamamlandı. Ortalama ameliyat süresi 328,4±105,8 dk ve kanama miktarı 131,7±170,3 mL idi. İki hastada intraoperatif komplikasyon gelişti (%2). İki hastada açık cerrahiye geçildi (%2). Çıkarılan ortalama lenf nodu sayısı 25,3±12,0 idi. Radyal sınır pozitifliği saptanan 4 hasta (%4) dışındaki tüm hastalarda cerrahi sınırlar temiz bulundu. İnkomplet mezorektal fasya bütünlüğü oranı %3,2 idi. Ortalama hastanede yatış süresi 6,6±3,6 gün ve postoperatif toplam morbidite oranı %25 idi. Sonuç: da Vinci Xi modeli rektum kanseri ameliyatlarının tamamen robotik yapılmasını mümkün kılmaktadır. Robotun bu özelliği cerrahın ameliyatın tüm aşamalarında robotik cerrahinin avantajlarından optimal bir şekilde faydalanmasını sağlamaktadır.

🔖

Cite This Article

AYTAÇ, E., KARAHASANOĞLU, T., BACA, B., HAMZAOĞLU, İ., BOĞA, S. A., DOĞRUÖZ, A., ÖZBEN, V. (2022). Robotic Rectal Cancer Surgery with the da Vinci Xi System: First 100 Cases. İstanbul Medical Journal, Cilt: 20 - Sayı: 1, 1–7. https://ajindex.com/articles/551969

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery-- the clue to pelvic recurrence? Br J Surg 1982; 69: 613-6
  2. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-46. 3. van der Pas MH, Haglind E, Cuesta MA, Fürst A, Lacy AM, Hop WC, et al; COlorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 2013; 14: 210-8
  3. Jayne DG, Thorpe HC, Copeland J, Quirke P, Brown JM, Guillou PJ. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg 2010; 97: 1638-45
  4. Shearer R, Gale M, Aly OE, Aly EH. Have early postoperative complications from laparoscopic rectal cancer surgery improved over the past 20 years? Colorectal Dis 2013; 15: 1211-26
  5. Stevenson AR, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ, et al; ALaCaRT Investigators. Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: The ALaCaRT randomized clinical trial. JAMA 2015; 314: 1356-63
  6. Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, et al; MRC CLASICC trial group. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005; 365: 1718-26
  7. Scarpinata R, Aly EH. Does robotic rectal cancer surgery offer improved early postoperative outcomes? Dis Colon Rectum 2013; 56: 253-62
  8. Pigazzi A, Ellenhorn JD, Ballantyne GH, Paz IB. Robotic-assisted laparoscopic low anterior resection with total mesorectal excision for rectal cancer. Surg Endosc 2006; 20: 1521-5
  9. Park IJ, You YN, Schlette E, Nguyen S, Skibber JM, Rodriguez-Bigas MA, et al. Reverse-hybrid robotic mesorectal excision for rectal cancer. Dis Colon Rectum 2012; 55: 228-33
  10. Koh DC, Tsang CB, Kim SH. A new application of the four-arm standard da Vinci® surgical system: totally robotic-assisted left-sided colon or rectal resection. Surg Endosc 2011; 25: 1945-52
  11. Ozben V, Cengiz TB, Atasoy D, Bayraktar O, Aghayeva A, Erguner I, et al. Is da Vinci Xi Better than da Vinci Si in Robotic Rectal Cancer Surgery? Comparison of the 2 Generati